Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2028

Date: January 1, 2019
Pages: 100
Price:
US$ 6,250.00
License [?]:
Publisher: DelveInsight
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S88E30F4611EN
Leaflet:

Download PDF Leaflet

Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2028
This report can be delivered to the clients within 7-10 Business Days

DelveInsight's 'Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2028' report provides a detailed analysis of the Sleep Apnea epidemiology and market outlook for the 7MM.

MARKETS COVERED
  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2016-2028

Sleep Apnea Understanding and Treatment Algorithm

The market report provides the overview of the Sleep Apnea by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.
Sleep Apnea Epidemiology

The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2016 to 2028 segmented by seven major markets, enabling to understand the potential of the Sleep Apnea in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.
Sleep Apnea Product Profiles & Analysis

The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.
Sleep Apnea Market Outlook

The report’s market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Sleep Apnea market.
Sleep Apnea Market Share by Therapies

This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2028. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.
Sleep Apnea Report Insights
  • Patient Population in Sleep Apnea
  • Therapeutic Approaches in Sleep Apnea
  • Sleep Apnea Pipeline Analysis
  • Sleep Apnea Market Size and Trends
  • Sleep Apnea Market Opportunities
  • Impact of upcoming Therapies in Sleep Apnea
Sleep Apnea Report Key Strengths
  • 10 Year Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition
Sleep Apnea Report Assessment
  • Current Treatment Practices in Sleep Apnea
  • Unmet Needs in Sleep Apnea
  • Market Attractiveness
  • Market Drivers and Barriers
KEY BENEFITS
  • The report will help to develop Business Strategies by understanding the trends shaping and driving the Sleep Apnea market
  • Organize sales and marketing efforts by identifying the best opportunities for Sleep Apnea market
  • To understand the future market competition in the Sleep Apnea market.
1. REPORT INTRODUCTION

2. SLEEP APNEA MARKET OVERVIEW AT A GLANCE

2.1. Market Share Distribution of Sleep Apnea in 2016
2.2. Market Share Distribution of Sleep Apnea in 2028

3. DISEASE BACKGROUND AND OVERVIEW: SLEEP APNEA

3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment

4. EPIDEMIOLOGY AND PATIENT POPULATION

4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Sleep Apnea in 7MM
4.3. Total Prevalent Patient Population of Sleep Apnea in 7MM – By Countries

5. EPIDEMIOLOGY OF SLEEP APNEA BY COUNTRIES

5.1. United States
  5.1.1. Assumptions and Rationale
  5.1.2. Prevalent/Incident Cases of the Sleep Apnea
  5.1.3. Sub-Type Specific cases of the Sleep Apnea
  5.1.4. Sex- Specific Cases of the Sleep Apnea
  5.1.5. Diagnosed Cases of the Sleep Apnea
  5.1.6. Treatable Cases of the Sleep Apnea
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
  5.4.1. Assumptions and Rationale
  5.4.2. Prevalent/Incident Cases of the Sleep Apnea
  5.4.3. Sub-Type Specific cases of the Sleep Apnea
  5.4.4. Sex- Specific Cases of the Sleep Apnea
  5.4.5. Diagnosed Cases of the Sleep Apnea
  5.4.6. Treatable Cases of the Sleep Apnea
5.5. France
  5.5.1. Assumptions and Rationale
  5.5.2. Prevalent/Incident Cases of the Sleep Apnea
  5.5.3. Sub-Type Specific cases of the Sleep Apnea
  5.5.4. Sex- Specific Cases of the Sleep Apnea
  5.5.5. Diagnosed Cases of the Sleep Apnea
  5.5.6. Treatable Cases of the Sleep Apnea
5.6. Italy
  5.6.1. Assumptions and Rationale
  5.6.2. Prevalent/Incident Cases of the Sleep Apnea
  5.6.3. Sub-Type Specific cases of the Sleep Apnea
  5.6.4. Sex- Specific Cases of the Sleep Apnea
  5.6.5. Diagnosed Cases of the Sleep Apnea
  5.6.6. Treatable Cases of the Sleep Apnea
5.7. Spain
  5.7.1. Assumptions and Rationale
  5.7.2. Prevalent/Incident Cases of the Sleep Apnea
  5.7.3. Sub-Type Specific cases of the Sleep Apnea
  5.7.4. Sex- Specific Cases of the Sleep Apnea
  5.7.5. Diagnosed Cases of the Sleep Apnea
  5.7.6. Treatable Cases of the Sleep Apnea
5.8. United Kingdom
  5.8.1. Assumptions and Rationale
  5.8.2. Prevalent/Incident Cases of the Sleep Apnea
  5.8.3. Sub-Type Specific cases of the Sleep Apnea
  5.8.4. Sex- Specific Cases of the Sleep Apnea
  5.8.5. Diagnosed Cases of the Sleep Apnea
  5.8.6. Treatable Cases of the Sleep Apnea
5.9. Japan
  5.9.1. Assumptions and Rationale
  5.9.2. Prevalent/Incident Cases of the Sleep Apnea
  5.9.3. Sub-Type Specific cases of the Sleep Apnea
  5.9.4. Sex- Specific Cases of the Sleep Apnea
  5.9.5. Diagnosed Cases of the Sleep Apnea
  5.9.6. Treatable Cases of the Sleep Apnea

6. CURRENT TREATMENT & MEDICAL PRACTICES

6.1. Treatment Algorithm
6.2. Treatment Guidelines

7. UNMET NEEDS OF THE SLEEP APNEA

8. MARKETED THERAPIES

8.1. Drug A: Company
  8.1.1. Drug Description
  8.1.2. Mechanism of Action
  8.1.3. Regulatory Milestones
  8.1.4. Advantages & Disadvantages
  8.1.5. Product Profile
8.2. Drug B: Company
  8.2.1. Drug Description
  8.2.2. Mechanism of Action
  8.2.3. Regulatory Milestones
  8.2.4. Advantages & Disadvantages
  8.2.5. Product Profile

9. PIPELINE THERAPIES – AT A GLANCE

10. KEY CROSS COMPETITION

11. EMERGING THERAPIES FOR SLEEP APNEA

11.1. Drug C: Company
  11.1.1. Drug Description
  11.1.2. Clinical Trials Details
  11.1.3. Safety and Efficacy Profile
  11.1.4. Advantages & Disadvantages
  11.1.5. Pipeline Development Activities
  11.1.6. Product Profile
11.2. Drug D: Company
  11.2.1. Drug Description
  11.2.2. Clinical Trials Details
  11.2.3. Safety and Efficacy Profile
  11.2.4. Advantages & Disadvantages
  11.2.5. Pipeline Development Activities
  11.2.6. Product Profile

12. SLEEP APNEA: 7MM MARKET ANALYSIS

12.1. 7MM Market Size of Sleep Apnea
12.2. 7MM Percentage Share of drugs marketed for Sleep Apnea
12.3. 7MM Market Sales of Sleep Apnea by Products

13. SLEEP APNEA: COUNTRY-WISE MARKET ANALYSIS

13.1. United States
  13.1.1. Market Size of Sleep Apnea in United States
  13.1.2. Percentage Share of drugs marketed for Sleep Apnea in United States
  13.1.3. Market Sales of Sleep Apnea by Products in United States
  13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
  13.2.1. Germany
    13.2.1.1. Market Size of Sleep Apnea in Germany
    13.2.1.2. Percentage Share of drugs marketed for Sleep Apnea in Germany
    13.2.1.3. Market Sales of Sleep Apnea by Products in Germany
    13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.2. France
    13.2.2.1. Market Size of Sleep Apnea in France
    13.2.2.2. Percentage Share of drugs marketed for Sleep Apnea in France
    13.2.2.3. Market Sales of Sleep Apnea by Products in France
    13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.3. Italy
    13.2.3.1. Market Size of Sleep Apnea in Italy
    13.2.3.2. Percentage Share of drugs marketed for Sleep Apnea in Italy
    13.2.3.3. Market Sales of Sleep Apnea by Products in Italy
    13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.4. Spain
    13.2.4.1. Market Size of Sleep Apnea in Spain
    13.2.4.2. Percentage Share of drugs marketed for Sleep Apnea in Spain
    13.2.4.3. Market Sales of Sleep Apnea by Products in Spain
    13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.5. United Kingdom
    13.2.5.1. Market Size of Sleep Apnea in United Kingdom
    13.2.5.2. Percentage Share of drugs marketed for Sleep Apnea in United Kingdom
    13.2.5.3. Market Sales of Sleep Apnea by Products in United Kingdom
    13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
  13.3.1. Market Size of Sleep Apnea in Japan
  13.3.2. Percentage Share of drugs marketed for Sleep Apnea in Japan
  13.3.3. Market Sales of Sleep Apnea by Products in Japan
  13.3.4. Analysis of Upcoming Therapies and their Impact on the Market

14. MARKET DRIVERS

15. MARKET BARRIERS

16. APPENDIX

17. REPORT METHODOLOGY

17.1. Sources

18. DELVEINSIGHT CAPABILITIES

19. DISCLAIMER

20. ABOUT DELVEINSIGHT

Indication Specific


LIST OF TABLES

Table 1: Total Prevalent/Incident Cases of the Sleep Apnea in 7MM
Table 2: Total Prevalent/Incident Cases of the Sleep Apnea in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Sleep Apnea in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Sleep Apnea in United States (2016-2028)
Table 5: Sex- Specific Cases of the Sleep Apnea in United States (2016-2028)
Table 6: Diagnosed Cases of the Sleep Apnea in United States (2016-2028)
Table 7: Treatable Cases of the Sleep Apnea in United States (2016-2028)
Table 8: Prevalent/Incident Cases of the Sleep Apnea in Germany (2016-2028)
Table 9: Sub-Type Specific cases of the Sleep Apnea in Germany (2016-2028)
Table 10: Sex- Specific Cases of the Sleep Apnea in Germany (2016-2028)
Table 11: Diagnosed Cases of the Sleep Apnea in Germany (2016-2028)
Table 12: Treatable Cases of the Sleep Apnea in Germany (2016-2028)
Table 13: Prevalent/Incident Cases of the Sleep Apnea in France (2016-2028)
Table 14: Sub-Type Specific cases of the Sleep Apnea in France (2016-2028)
Table 15: Sex- Specific Cases of the Sleep Apnea in France (2016-2028)
Table 16: Diagnosed Cases of the Sleep Apnea in France (2016-2028)
Table 17: Treatable Cases of the Sleep Apnea in France (2016-2028)
Table 18: Prevalent/Incident Cases of the Sleep Apnea in Italy (2016-2028)
Table 19: Sub-Type Specific cases of the Sleep Apnea in Italy (2016-2028)
Table 20: Sex- Specific Cases of the Sleep Apnea in Italy (2016-2028)
Table 21: Diagnosed Cases of the Sleep Apnea in Italy (2016-2028)
Table 22: Treatable Cases of the Sleep Apnea in Italy (2016-2028)
Table 23: Prevalent/Incident Cases of the Sleep Apnea in Spain (2016-2028)
Table 24: Sub-Type Specific cases of the Sleep Apnea in Spain (2016-2028)
Table 25: Sex- Specific Cases of the Sleep Apnea in Spain (2016-2028)
Table 26: Diagnosed Cases of the Sleep Apnea in Spain (2016-2028)
Table 27: Treatable Cases of the Sleep Apnea in Spain (2016-2028)
Table 28: Prevalent/Incident Cases of the Sleep Apnea in UK (2016-2028)
Table 29: Sub-Type Specific cases of the Sleep Apnea in UK (2016-2028)
Table 30: Sex- Specific Cases of the Sleep Apnea in UK (2016-2028)
Table 31: Diagnosed Cases of the Sleep Apnea in UK (2016-2028)
Table 32: Treatable Cases of the Sleep Apnea in UK (2016-2028)
Table 33: Prevalent/Incident Cases of the Sleep Apnea in Japan (2016-2028)
Table 34: Sub-Type Specific cases of the Sleep Apnea in Japan (2016-2028)
Table 35: Sex- Specific Cases of the Sleep Apnea in Japan (2016-2028)
Table 36: Diagnosed Cases of the Sleep Apnea in Japan (2016-2028)
Table 37: Treatable Cases of the Sleep Apnea in Japan (2016-2028)
Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Sleep Apnea in USD MM (2016-2028)
Table 42:7MM- Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 43:7MM- Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 44: United States-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 45: United States-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 46: United States-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 47: Germany-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 48: Germany-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 49: Germany-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 50: France-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 51: France-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 52: France-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 53: Italy-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 54: Italy-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 55: Italy-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 56: Spain-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 57: Spain-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 58: Spain-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 59:UK-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 60:UK-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 61:UK-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Table 62: Japan-Market Size of Sleep Apnea in USD MM (2016-2028)
Table 63: Japan-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Table 64: Japan-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)

LIST OF FIGURES

Figure 1: Total Prevalent/Incident Cases of the Sleep Apnea in 7MM
Figure 2: Total Prevalent/Incident Cases of the Sleep Apnea in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Sleep Apnea in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Sleep Apnea in United States (2016-2028)
Figure 5: Sex- Specific Cases of the Sleep Apnea in United States (2016-2028)
Figure 6: Diagnosed Cases of the Sleep Apnea in United States (2016-2028)
Figure 7: Treatable Cases of the Sleep Apnea in United States (2016-2028)
Figure 8: Prevalent/Incident Cases of the Sleep Apnea in Germany (2016-2028)
Figure 9: Sub-Type Specific cases of the Sleep Apnea in Germany (2016-2028)
Figure 10: Sex- Specific Cases of the Sleep Apnea in Germany (2016-2028)
Figure 11: Diagnosed Cases of the Sleep Apnea in Germany (2016-2028)
Figure 12: Treatable Cases of the Sleep Apnea in Germany (2016-2028)
Figure 13: Prevalent/Incident Cases of the Sleep Apnea in France (2016-2028)
Figure 14: Sub-Type Specific cases of the Sleep Apnea in France (2016-2028)
Figure 15: Sex- Specific Cases of the Sleep Apnea in France (2016-2028)
Figure 16: Diagnosed Cases of the Sleep Apnea in France (2016-2028)
Figure 17: Treatable Cases of the Sleep Apnea in France (2016-2028)
Figure 18: Prevalent/Incident Cases of the Sleep Apnea in Italy (2016-2028)
Figure 19: Sub-Type Specific cases of the Sleep Apnea in Italy (2016-2028)
Figure 20: Sex- Specific Cases of the Sleep Apnea in Italy (2016-2028)
Figure 21: Diagnosed Cases of the Sleep Apnea in Italy (2016-2028)
Figure 22: Treatable Cases of the Sleep Apnea in Italy (2016-2028)
Figure 23: Prevalent/Incident Cases of the Sleep Apnea in Spain (2016-2028)
Figure 24: Sub-Type Specific cases of the Sleep Apnea in Spain (2016-2028)
Figure 25: Sex- Specific Cases of the Sleep Apnea in Spain (2016-2028)
Figure 26: Diagnosed Cases of the Sleep Apnea in Spain (2016-2028)
Figure 27: Treatable Cases of the Sleep Apnea in Spain (2016-2028)
Figure 28: Prevalent/Incident Cases of the Sleep Apnea in UK (2016-2028)
Figure 29: Sub-Type Specific cases of the Sleep Apnea in UK (2016-2028)
Figure 30: Sex- Specific Cases of the Sleep Apnea in UK (2016-2028)
Figure 31: Diagnosed Cases of the Sleep Apnea in UK (2016-2028)
Figure 32: Treatable Cases of the Sleep Apnea in UK (2016-2028)
Figure 33: Prevalent/Incident Cases of the Sleep Apnea in Japan (2016-2028)
Figure 34: Sub-Type Specific cases of the Sleep Apnea in Japan (2016-2028)
Figure 35: Sex- Specific Cases of the Sleep Apnea in Japan (2016-2028)
Figure 36: Diagnosed Cases of the Sleep Apnea in Japan (2016-2028)
Figure 37: Treatable Cases of the Sleep Apnea in Japan (2016-2028)
Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 42:7MM- Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 43:7MM- Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 44: United States-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 45: United States-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 46: United States-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 47: Germany-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 48: Germany-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 49: Germany-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 50: France-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 51: France-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 52: France-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 53: Italy-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 54: Italy-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 55: Italy-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 56: Spain-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 57: Spain-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 58: Spain-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 59:UK-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 60:UK-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 61:UK-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 62: Japan-Market Size of Sleep Apnea in USD MM (2016-2028)
Figure 63: Japan-Market Share Sleep Apnea by Therapies in USD MM (2016-2028)
Figure 64: Japan-Market Sales of Sleep Apnea by Therapies in USD MM (2016-2028)
Skip to top


Sleep Apnea - Epidemiology Forecast to 2028 US$ 3,250.00 Jan, 2019 · 50 pages
Sleep Apnea - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 · 50 pages
Global Sleep Apnea US$ 4,200.00 Apr, 2017 · 326 pages

Ask Your Question

Sleep Apnea - Market Insight, Epidemiology and Market Forecast - 2028
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: